Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE approves Lynparza plus Avastin via Cancer Drugs Fund

pharmatimesMarch 19, 2021

Tag: NICE , Lynparza , Avastin , ovarian cancer

PharmaSources Customer Service